References

Atfy, M., G.E. Amr, A.M. Elnaggar, H.A. Labib, A. Esh and A.M. Elokely, 2009. Impact of CD4⁺CD25 high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus. Egypt. J. Immunol., 16: 117-126.
PubMed  |  

Becker, K., D. Kindrick, R. McCarron, J. Hallenbeck and R. Winn, 2003. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: A role for lymphocytes in ischemic brain injury. Stroke, 34: 1809-1815.
PubMed  |  

Bourreau, E., C. Ronet, E. Darcissac, M.C. Lise and D.S. Marie et al., 2009. Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis. Infect. Immun., 77: 1465-1474.
PubMed  |  

Cobbold, S.P., L. Graca, C.Y. Lin, E. Adams and H. Waldmann, 2003. Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance. Trans. Int., 16: 66-75.
PubMed  |  

Cohen, J.L., A. Trenado, D. Vasey, D. Klatzmann and B.L. Salomon, 2002. CD4⁺CD25⁺ immunoregulatory T cells: New therapeutics for graft-versus-host disease. J. Exp. Med., 196: 401-406.
PubMed  |  

Fu, B.M., X.S. He, S. Yu, A.B. Hu and J. Zhang et al., 2010. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4⁺CD25⁺ T regulatory cells that promotes skin allograft survival in mice. Cell. Immunol., 261: 69-76.
PubMed  |  

Graca, L., S. Thompson, C.Y. Lin, E. Adams, S.P. Cobbold and H. Waldmann, 2002. Both CD4⁺CD25⁺ and CD4⁺CD25^- regulatory cells mediate dominant transplantation tolerance. J. Immunol., 168: 5558-5565.
PubMed  |  

Grupp, S.A. and C.H. June, 2010. Adoptive cellular therapy. Curr. Top. Microbiol. Immunol.,

Hall, B.M., K.M. Plain, N.D. Verma, G.T. Tran and R. Boyd et al., 2007. Transfer of allograft specific tolerance requires CD4⁺CD25⁺T cells but not interleukin-4 or transforming growth factor-β and cannot induce tolerance to linked antigens. Transplantation, 83: 1075-1084.
PubMed  |  

Hara, M., C.I. Kingsley, M. Niimi, S. Read and S.E. Turvey et al., 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol., 166: 3789-3796.
PubMed  |  

Houot, R., I. Perrot, E. Garcia, I. Durand and S. Lebecque, 2006. Human CD4⁺CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J. Immunol., 176: 5293-5298.
PubMed  |  

Jones, T.B. and A.M. Kaplan, 1977. Immunologic tolerance to HGG in mice. I. Suppression of the HGG response in normal mice with spleen cells or a spleen cell lysate from tolerant mice. J. Immunol., 118: 1880-1885.
PubMed  |  

Kappler, J.W., N. Roehm and P. Marrack, 1987. T cell tolerance by clonal elimination in the thymus. Cell, 49: 273-280.
PubMed  |  

Keller, J.M., P.D. McClellan-Green, A.M. Lee, M.D. Arendt and P.P. Maier et al., 2005. Mitogen-induced lymphocyte proliferation in loggerhead sea turtles: Comparison of methods and effects of gender, plasma testosterone concentration and body condition on immunity. Vet. Immunol. Immunopathol., 103: 269-281.
CrossRef  |  

Kohm, A.P., P.A. Carpentier, H.A. Anger and S.D. Miller, 2002. Cutting edge: CD4⁺CD25⁺ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol., 169: 4712-4716.
PubMed  |  

Kukreja, A., G. Cost, J. Marker, C. Zhang and Z. Sun et al., 2002. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest., 109: 131-140.
PubMed  |  

La Cava, A., 2008. T-regulatory cells in systemic lupus erythematosus. Lupus, 17: 421-425.
CrossRef  |  

Langhans, B., I. Braunschweiger, S. Arndt, W. Schulte and J. Satoguina et al., 2010. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Clin. Sci., 119: 97-109.
PubMed  |  

Lee, D.A., M.R. Verneris and D. Campana, 2010. Acquisition, preparation and functional assessment of human NK cells for adoptive immunotherapy. Methods Mol. Biol., 651: 61-77.
PubMed  |  

Li, M.O., Y.Y. Wan, S. Sanjabi, A.K.L. Robertson and R.A. Flavell, 2006. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol., 24: 99-146.
CrossRef  |  PubMed  |  Direct Link  |  

Lindley, S., C.M. Dayan, A. Bishop, B.O. Roep, M. Peakman and T.I. Tree, 2005. Defective suppressor function in CD4⁺CD25⁺ T-cells from patients with type 1 diabetes. Diabetes, 54: 92-99.
PubMed  |  

Liu, M.M., Z.G. Yuan, G.H. Peng, D.H. Zhou and X.H. He et al., 2010. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol. Res., 106: 1079-1084.
PubMed  |  

Long, T.T., S. Nakazawa, S. Onizuka, M.C. Huaman and H. Kanbara, 2003. Influence of CD4⁺CD25⁺ T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int. J. Parasitol., 33: 175-183.
PubMed  |  

Mahnke, K., T.S. Johnson, S. Ring and A.H. Enk, 2007. Tolerogenic dendritic cells and regulatory T cells: A two-way relationship. J. Dermatol. Sci., 46: 159-167.
PubMed  |  

Marie, J. C., J.J. Letterio, M. Gavin and A.Y. Rudensky, 2005. TGF-β1 maintains suppressor function and Foxp3 expression in CD4⁺CD25⁺ regulatory T cells. J. Exp. Med., 201: 1061-1067.
PubMed  |  

McHugh, R.S., M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, M. Collins and M.C. Byrne, 2002. CD4⁺CD25⁺ immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity, 16: 311-323.
CrossRef  |  PubMed  |  Direct Link  |  

Miyara, M., K. Wing and S. Sakaguchi, 2009. Therapeutic approaches to allergy and autoimmunity based on FoxP3⁺ regulatory T-cell activation and expansion. J. Allergy Clin. Immunol., 123: 749-755.
PubMed  |  

Morgan, M.E., R. Flierman, L.M. van Duivenvoorde, H.J. Witteveen and W. van Ewijk et al., 2005. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25⁺ regulatory T cells. Arthritis Rheum., 52: 2212-2221.
PubMed  |  

Mougiakakos, D., A. Choudhury, A. Lladser, R. Kiessling and C.C. Johansson, 2010. Regulatory T cells in cancer. Adv. Cancer Res., 107: 57-117.

Nakamura, K., A. Kitani and W. Strober, 2001. Cell contact-dependent immunosuppression by CD4⁺CD25⁺ regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med., 194: 629-644.
Direct Link  |  

Nakamura, K., A. Kitani, I. Fuss, A. Pedersen, N. Harada, H. Nawata and W. Strober, 2004. TGF-β1 plays an important role in the mechanism of CD4⁺CD25⁺ regulatory T cell activity in both humans and mice. J. Immunol., 172: 834-842.
PubMed  |  

Nishikawa, H. and S. Sakaguchi, 2010. Regulatory T cells in tumor immunity. Int. J. Cancer, 127: 759-767.

Onizuka, S., I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita and E. Nakayama, 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res., 59: 3128-3133.
PubMed  |  

Ostroukhova, M., C. Seguin-Devaux, T.B. Oriss, B. Dixon-McCarthy and L. Yang et al., 2004. Tolerance induced by inhaled antigen involves CD4⁺ T cells expressing membrane-bound TGF-beta and FOXP3. J. Clin. Invest., 114: 28-38.
PubMed  |  

Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner and D.A. Hafler, 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature, 346: 183-187.
PubMed  |  

Peng, G.H., Z.G. Yuan, D.H. Zhou, X.H. He and M.M. Liu et al., 2009. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine, 27: 6570-6574.
PubMed  |  Direct Link  |  

Rodrigues, O.R., C. Marques, M. Soares-Clemente, M.H. Ferronha and G.M. Santos-Gomes, 2009. Identification of regulatory T cells during experimental Leishmania infantum infection. Immunobiology, 214: 101-111.
PubMed  |  

Sakaguchi, S., 2004. Naturally arising CD4⁺ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol., 22: 531-562.
Direct Link  |  

Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh and M. Toda, 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 155: 1151-1164.
Direct Link  |  

Schumacher, T.N. and N.P. Restifo, 2009. Adoptive T cell therapy of cancer. Curr. Opin. Immunol., 21: 187-189.
CrossRef  |  

Shevach, E.M., R.S. McHugh, C.A. Piccirillo and A.M. Thornton, 2001. Control of T-cell activation by CD4⁺ CD25⁺ suppressor T cells. Immunol. Rev., 182: 58-67.
PubMed  |  

Shimizu, J., S. Yamazaki and S. Sakaguchi, 1999. Induction of tumor immunity by removing CD25⁺CD4⁺ T cells: A common basis between tumor immunity and autoimmunity. J. Immunol., 163: 5211-5218.
PubMed  |  

Shimizu, J., S. Yamazaki, T. Takahashi, Y. Ishida and S. Sakaguchi, 2002. Stimulation of CD25⁺CD4⁺ regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol., 3: 135-142.
PubMed  |  

Strid, J., M. Thomson, J. Hourihane, I. Kimber and S. Strobel, 2004. A novel model of sensitization and oral tolerance to peanut protein. Immunology, 13: 293-303.
PubMed  |  

Takahashi, T., Y. Iyasu, M. Toda, N. Sakaguchi and M. Itoh et al., 1998. Immunologic self-tolerance maintained by CD25⁺CD4⁺ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol., 10: 1969-1980.
PubMed  |  

Taniguchi, M. and J.F. Miller, 1978. Specific suppression of the immune response by a factor obtained from spleen cells of mice tolerant to human gamma-globulin. J. Immunol., 120: 21-26.
PubMed  |  

Turtle, C.J. and S.R. Riddell, 2010. Artificial antigen-presenting cells for use in adoptive immunotherapy. Canner J., 16: 374-381.
PubMed  |  

Vahlenkamp, T.W., M.B. Tompkins and W.A. Tompkins, 2005. The role of CD4⁺CD25⁺ regulatory T cells in viral infections. Vet. Immunol. Immunopathol., 108: 219-225.
PubMed  |  

Van Amelsfort, J.M., K.M. Jacobs, J.W. Bijlsma, F.P. Lafeber and L.S. Taams, 2004. CD4⁺CD25⁺ regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype and function between peripheral blood and synovial fluid. Arthritis Rheum., 50: 2775-2785.
PubMed  |  

Viglietta, V., C. Baecher-Allan, H.L. Weiner and D.A. Hafler, 2004. Loss of functional suppression by CD4⁺CD25⁺ regulatory T cells in patients with multiple sclerosis. J. Exp. Med., 199: 971-979.
Direct Link  |  

Wakkach, A., N. Fournier, V. Brun, J.P. Breittmayer, F. Cottrez and H. Groux, 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity, 18: 605-617.
PubMed  |  

Weiss, L., F.A. Letimier, M. Carriere, S. Maiella and V. Donkova-Petrini et al., 2010. In vivo expansion of naive and activated CD4⁺CD25⁺FOXP3⁺ regulatory T cell populations in interleukin-2-treated HIV patients. Proc. Nat. Acad. Sci. USA., 107: 10632-10637.
PubMed  |  

Wongyanin, P., S. Buranapraditkun, K. Chokeshai-Usaha, R. Thanawonguwech and S. Suradhat, 2010. Induction of inducible CD4⁺CD25⁺Foxp3⁺ regulatory T lymphocytes by Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). Vet. Immunol. Immunopathol., 133: 170-182.
PubMed  |  

Zhang, X., L. Izikson, L. Liu and H.L. Weiner, 2001. Activation of CD25⁺CD4⁺ regulatory T cells by oral antigen administration. J. Immunol., 167: 4245-4253.
PubMed  |